Safeguard Scientifics Q2 2023 net loss of $2.9M; six portfolio co. revenue up 12.8%

SAFEGUARD SCIENTIFICS INC

2023-Q2 EPS reported -$0.39

Net loss Q2 2023 of $2.9M ($0.18/sh) vs net income $0.5M ($0.03/sh) in Q2 2022.
Cash, cash equivalents & restricted cash total $15.1M at June 30, 2023.
Deployed $3.0M to Prognos; received $0.4M from Aktana note sale; no material position in Aktana after recap.
Aggregate trailing 12-month revenue for six portfolio companies $95M, up 12.8% YoY.
Corporate expenses fell 12.2% to $0.7M in Q2 2023 from $0.8M in Q2 2022.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SAFEGUARD SCIENTIFICS INC reported the three and six months ended June 30, 2023 results: net income Net loss for the three months ended June 30, 2023 was $2.9 million, or $0.18 per share.

Period: the three and six months ended June 30, 2023
Net income: Net loss for the three months ended June 30, 2023 was $2.9 million, or $0.18 per share
Result: reported results

Exact text from the filing

o Net loss for the three months ended June 30, 2023 was $2.9 million, or $0.18 per share, as compared with a net income of $0.5 million, or $0.03 per share, for the same period in 2022.

View on SEC.gov

22 earnings releases filed in the last 30 days. Browse all earnings releases →

SAFEGUARD SCIENTIFICS INC filing history →

Source: SEC EDGAR

accession 0001437749-23-023041

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.